Impact of Animal-Assisted Interaction on Anxiety in Children With Advanced Cancer and Their Caregivers
Journal of Palliative Medicine · 2024
DOI: 10.1089/jpm.2023.0091 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Palliative Medicine, 2024. Verfasst von Anne Byrd Mahoney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology/Oncology, Vanderbilt University Medical Center and Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville…. Hauptthemen laut MEDLINE: Caregivers, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NCATS NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Pediatric patients with advanced cancer and their caregivers have unique psychosocial needs. Anxiety often worsens throughout treatment for both patients and parents, and, if undertreated, can cause suffering. Animal-assisted interaction (AAI) incorporates animals into patient care in a structured manner for the purpose of therapeutic benefit.
Objective
To evaluate feasibility of incorporating AAI into patient care and to assess AAI effectiveness in decreasing patient and caregiver anxiety in pediatric patients with advanced cancer, defined by relapsed or refractory disease.
Design
Randomized controlled study. Setting/Subjects: Participants were children ( n = 19) and parents ( n = 21) who were randomized to AAI group or usual care (UC) group. Measures: Participants completed weekly measures to assess anxiety, including the 20-question State-Trait Anxiety Inventory (STAI).
Results
Our results demonstrated feasibility of the use of AAI in children with advanced cancer. While they did not reveal a significant difference in anxiety scores over the four sessions in either group, parents randomized to the AAI group had lower STAI State subscores at initial visit in comparison to the UC group. The difference in initial STAI State anxiety scores for caregivers may indicate a positive effect of AAI in reducing anxiety surrounding appointments through anticipation of seeing a therapy dog.
Conclusion
Further research is needed to determine the effectiveness of AAI in pediatric patients with advanced cancer and their caregivers, but results are promising that participation in AAI may lessen caregiver anxiety. Clinical Trial Registration Number is: NCT03765099
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Hematology/Oncology, Vanderbilt University Medical Center and Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, USA.
- Family Care Community, Vanderbilt University School of Nursing, Nashville, Tennessee, USA.
- Division of Hospice and Palliative Medicine, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, Texas, USA.
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Peabody College, Vanderbilt University, Nashville, Tennesse, USA.
Förderung
- NICHD NIH HHS
- NCATS NIH HHS
Zitieren
APA
Mahoney, A. B., Akard, T. F., Cowfer, B. A., Dietrich, M. S., Newton, J. L., & Gilmer, M. J. (2024). Impact of Animal-Assisted Interaction on Anxiety in Children With Advanced Cancer and Their Caregivers. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2023.0091
Vancouver
Mahoney AB, Akard TF, Cowfer BA, Dietrich MS, Newton JL, Gilmer MJ. Impact of Animal-Assisted Interaction on Anxiety in Children With Advanced Cancer and Their Caregivers. Journal of Palliative Medicine. 2024. doi:10.1089/jpm.2023.0091
BibTeX
@article{Mahoney2024,
author = {Mahoney, Anne Byrd and Akard, Terrah Foster and Cowfer, Brittany A and Dietrich, Mary S and Newton, Jennifer L and Gilmer, Mary Jo},
title = {Impact of Animal-Assisted Interaction on Anxiety in Children With Advanced Cancer and Their Caregivers},
journal = {Journal of Palliative Medicine},
year = {2024},
doi = {10.1089/jpm.2023.0091}
}
EUVIMED